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 Research in our laboratory is focused on understanding the molecular 
developmental genetic effects of crude oil exposure on vertebrate embryogenesis.  Our 
research has demonstrated that exposure of zebrafish embryos to crude oil results in 
characteristic developmental anomalies marked by pericardial edema, progressive 
deterioration of the developing heart and cardiac stasis coupled with larval death 
(Ghiassi, 2014).  Chopra et al. observed very similar developmental defects after 
antisense oligonucleotide (MO)-mediated knockdown of the voltage-gated sodium ion 
channel genes scn5Laa and ab (Chopra et al. 2010).  They further demonstrated that 
the developmental defects induced by the zebrafish scn5Laa and ab-directed MO’s 
acted independently of their effects as ion channel disrupters, indicative that the 
scn5Laa and ab gene-encoded proteins have separate ion channel and developmental 
functions.  Since knockdown of zebrafish scn5Laa and ab induce defects that effectively 
phenocopy the teratogenic effects of crude oil in the zebrafish model, we wanted to 
 verify that the scn5Laa and ab genes function in normal zebrafish heart development.  
Since MO-mediated gene knockdown phenotypes are often associated with off-target 
MO activities, verification of the activity of these genes in development required gene 
knockouts.  Therefore, the aim of this research was to create zebrafish scn5Laa and 
scn5Lab gene knockouts using both TALENs and CRISPR-CAS9 gene editing methods 
and to determine whether these knockout mutants mirror the phenotypes observed by 
Chopra et al. (Chopra et al. 2010).  Assuming that the effects of MO’s on translation of 
scn5Laa and scn5Lab gene-derived mRNA are specific and results in gene knockdowns 
that directly affect embryonic heart development, we hypothesized that the zebrafish 
scn5Laa and ab gene knockouts would generate developmental defects similar to those 
reported by Chopra et al. (Chopra et al. 2010).  To test our hypothesis, we created 
homozygous zebrafish scn5Laa and ab frameshift mutants using both TALENs and 
CRISPR-CAS9 gene editing methods.  Screening of independent homozygous scn5Laa 
and scn5Lab frameshift mutant alleles for developmental defects, failed to demonstrate 
an increase in embryos with defects above frequencies observed among appropriate 
wild-type zebrafish controls. Since Chopra et al. (2010) observed stereotypical 
development heart defects among zebrafish treated independently with MO’s directed 
toward either scn5Laa or scn5Lab genes, we reject the hypothesis that independent 
scn5Laa or ab gene knockout can generate mutants with developmental heart defects 
that mirror those induced by MO’s.  The absence of developmental heart defects among 
zebrafish bearing frameshift mutations in either scn5Laa or ab suggest that these genes 
act independently are not responsible for specification of normal zebrafish heart 
development.  It is, however, possible that the absence of a detectable heart defect 
 among knockout mutants may reflect the fact that both paralogs are required for normal 
heart specification and that Chopra et al.’s (2010) MO treatment with individual MO’s 
simultaneously affected the expression of both genes. If so, then double knockouts of 
scn5Laa and ab would be required to recapitulate the heart developmental defects 
reported by Chopra et al. (2010).  It is also possible that other members of the Na+ ion 
channel family proteins are required for normal heart development and that Chopra et 
al.’s MO knocked down their activities sufficiently to induce developmental heart 
defects. If so, additional gene knockouts for additional members of the Na+ ion channel 
family genes would have to be constructed and tested separately or in combination to 
test this hypothesis.  It is also possible that the Chopra et al. results were attributable to 
widely acknowledged MO off-target, non-specific effects. Future experiments including 
the screening of scn5Laa and ab double mutants, will provide information about whether 
both  genes are required to specify normal heart development and whether the results 
reported by Chopra et al (2010) were related to simultaneous knockdown of scn5a 
paralogs by single MOs. 
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CHAPTER 1: INTRODUCTION  
Effect of crude oil exposure on vertebrate embryonic development 
Despite the increasing number of environmental oil spills, especially the 
disastrous 2010 spill in the Gulf of Mexico, little is understood about the genetic and 
developmental effects of crude oil exposure on embryonic stage vertebrates. Based on 
this paucity of information, our laboratory has been examining the developmental 
response of zebrafish embryos to crude oil exposure to determine if there are 
characteristic developmental defects and, if so, to characterize the underlying genetic 
and biochemical mechanisms leading to these defects.  
Evidence from limited field and laboratory studies have shown that exposure of 
embryonic stage fish to crude oil results in major defects in jaw, pharyngeal arch, spine,  
craniofacial and heart development (Pauka et al. 2011; Machlis et al. 2010; Crone and 
Tolstoy 2010; Incardona et al. 2011; Incardona et al. 2004; Incardona et al. 2005; Carls 
et al. 2008; Carls et al. 1999; Heintz et al. 1999). The earliest and most readily 
identifiable defects are related to heart development and are manifested in field and 
laboratory studies by extreme pericardial edema followed by aberrant heart 
development marked by progressive wasting of the developing heart tissue, abnormal 
rhythms and reduced heart rate leading to cessation of the heart beating and blood 
circulation.  Similar developmental defects have been demonstrated in embryonic stage 
fish after exposure to complex mixtures of polycyclic aromatic hydrocarbons, which 
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constitute a high percentage of the non-aliphatic hydrocarbons in crude oil (Hicken et al. 
2011). 
While the morphological defects induced by crude oil exposure in developing fish 
embryos are documented in both field and laboratory studies, little is known about the 
molecular nature of these defects.  Based on gene expression and enzyme activity 
measurements, it has been determined that aryl hydrocarbon metabolizing enzymes 
and receptors are induced and that certain stress response pathways are elevated after 
exposure (Incardona et al. 2005; Nebert et al. 2004).  However, the effects of crude oil 
exposure on genes involved in heart development and function are unknown. 
Detailed stereomicroscopic studies of crude oil-treated zebrafish embryos 
conducted in our laboratory and similar studies by de Soysa et al. (2012) have shown 
that the embryonic heart develops abnormally during a protracted period beginning at 
about 48 hour post-fertilization and continuing through the larval stage of growth; 
terminating in larval death usually around 10-12 days post-fertilization (Ghiassi 2014; de 
Soysa et al. 2012).  During this period the embryonic and larval heart appears to 
undergo progressive thinning of the atrial and ventricular walls with a failure to engage 
in characteristic looping and marked by continual reduction in heart rate (de Soysa et al. 
2012).  These morphological changes occur concurrently with continuous expansion of 
the pericardial sac leading to extreme pericardial edema, which suggests osmotic 
imbalance in the pericardium. 
An examination of the zebrafish development literature revealed a number of 
mutants with defects in heart development similar to those observed after crude oil 
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treatment of embryos (Belaire et al. 2001; Henry et al. 1997). These include mutants 
that showed cardiac and yolk sac edema, cardiac arrhythmia, reduced larval heart rate 
and abnormal heart development.  While these mutants are of significance because 
they suggest that single gene defects phenocopy the developmental heart defects 
induced by crude oil exposure, they have not been characterized genetically and so do 
not provide information about the specific gene expression or biochemical processes 
that could be affected by crude oil exposure.  However, there is evidence from gene 
knockdown studies that a pair of gene paralogs that encode specific Na+ ion channels- 
also phenocopy the developmental heart defects that have been observed after 
treatment of zebrafish embryos with crude oil (Chopra et al. 2010).  A report by Chopra 
et al. (2010) showed that the independent or combined knockdown of either of two 
voltage gated Na+ ion channel genes (scn5Laa and scn5Lab) using antisense 
morpholino oligonucleotides (MO) in zebrafish resulted in a phenocopy of the heart 
defects induced after crude oil exposure of embryos.   
Expression studies using riboprobes directed toward these two genes show that 
they are expressed in the myocardium of the developing heart (Novak and Taylor et al. 
2006). Treatment of embryos with Na+ channel ion blocking agents that inhibited the ion 
channel activity of the scn5Laa and ab-encoded proteins failed to generate the heart 
development defects induced by the scn5Laa and ab MO-directed gene knockdown 
which suggests that these ion channels may have distinct functions both as ion 
channels and separately as factors required for normal heart development (Chopra 
2008).  While the results reported by Chopra et al. (2010) are indicative that the 
scn5Laa and ab gene-encoded protein products may be those that are affected by 
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crude oil exposure, MO-induced knockdown phenotypes are sometimes the product of 
MO-related toxicity or off-target effects (Chopra 2008).  They could also arise because 
of MO-mediated knockdown of gene expression among genetically-related Na+ ion 
channel protein family members. In order to ensure that the MO-induced phenotypes 
are authentic and specific, it is necessary to isolate gene knockouts for both of these 
genes to determine if scn5Laa and Lab gene knockout mutant’s developmental 
phenotypes mirror those reported by Chopra et al. (2010). 
Molecular Structure of zebrafish scn5Laa and Lab genes 
In zebrafish, the voltage gated Na+ ion channel gene (scn) family is composed of 
eight alpha subunit genes and four beta (z1-z4) subunit genes (Novak et al. 2006; 
Chopra, Watanabe et al. 2007). In zebrafish,  subunit of scn genes are composed of 
four sets of duplicated genes called scn1Laa and scn1Lab, scn4aa and scn4ab, 
scn5Laa and scn5Lab, scn8aa and scn8ab (Novak et al. 2006). These genes in the scn 
family have high sequence similarities within the transmembrane repeat regions and ion 
channel coding regions. In addition, members of duplicated genes show higher 
similarities in their nucleotide and amino acid sequences (Novak et al. 2006). The scn 
family is unusual in zebrafish because all the duplicated genes have been retained 
since their divergence from a common ancestral gene. When duplicated genes are 
retained, it is usually because their functions diverge and the duplicates are both under 
selection or because the genes diverge and assume subfunctions of the original 
ancestral gene (Postlethwait et al. 2004). In either case, the evolutionary pathway of 
these gene duplicates, particularly the scn5 paralogs, influence how these genes 
function relative to each other.  In the case of duplicate subfunctionalized genes, one 
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might expect that expression occurs in different tissues of the same organ or different 
cell-types in the same tissue or regions.   By contrast, if the genes diverged in function, 
they might be expressed and function differently in completely different tissues or cells.   
Scn5Laa is located on chromosome 2 while scn5Lab is located on chromosome 
24 in zebrafish (Kersey et al. 2013). The length of mature mRNA of scn5Laa is 5799 bp 
(accession # DQ149507) comprising 27 exons that span 6.6 kb (Figure 2) (Kersey et al. 
2013). The mature mRNA length of scn5Lab is 5865 bp (accession # DQ149508) 
containing 29 exons that span 6.5 kb (Figure 3) (Kersey et al. 2013). A comparison of 
the scn5Laa and ab transcripts shows that transcripts of scn5Laa are first expressed at 
24hpf in the developing heart tube of zebrafish (Novak, Taylor et al. 2006), appear in 
the hind brain and mid-brain regions at 48 hpf and then throughout the rostral region of 
the nervous system by 60 hpf (Novak, Taylor et al. 2006). By comparison, the 
expression of scn5Lab mRNA transcripts are seen as early as 19 hpf in trunk somites, 
in spinal cord by 30 hpf, and a low expression in anterior and posterior lateral line 
nerves by 60 hpf (Novak, Taylor et al. 2006).  
The primary protein structure of scn5Laa and ab gene-encoded proteins is 1932 
amino acid long and 1954 amino acids, respectively. These genes encode proteins that 
form the  subunit of the Na+ ion channels. The  subunit of sodium ion channel 
proteins is larger than that of the beta subunit comprising a ~240kDa protein with 24 
membrane spanning domains compared to the β subunit typically a 30-40kDa protein 
“with a single transmembrane domain and an extracellular V-type immunoglobin-like 
domain (Chopra 2008)” (Isom et al. 1992; Isom et al. 1995; Morgan et al. 2000; Yu et al. 
2003; Isom and Catterall 1996). The tertiary structure of a typical voltage gated sodium 
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channel includes four homologous domains called DI-DIV (Figure 1). Each of these 
domains are comprised of six membrane spanning segments S1-S6 (Marban et al. 
1998; George Jr. 2005; Roden et al. 2002). Segments S5-S6 predominantly forms the 
pore’s channel (Figure 1). Evidence from biophysical studies show that the residues 
D(DI), E(DII), K(DIII), A(DIV) specify each channel’s ion selectivity (Sun et al. 1997). 
Domains III and IV forms an intracellular linker that acts as an ion inactivation gate to 
form ion permeable pathways into the membrane during repolarization state (Figure 1). 
The S4 transmembrane segment is comprised of charged residues of arginine or lysine 
at every third position and are suspected to play a significant role in depolarization to 
open the channels (Figure 1) (Sun et al. 1997). In the tertiary structure of  subunit, the 
four homologous domains are predicted to form a fourfold symmetry surrounding S5-S6 
interlink dipping down into the membrane forming a central pore (Lehmann-Horn and 
Jurkat-Rott 1999). The S1-S3 segments are thought to reside near the lipid bilayer 
because of their amphipathic nature to interact with polypeptides and lipids (Guy and 
Durell 1995) while S5-S6 segments are located near the central pore establishing a 
narrow selectivity filter. The S4 segment is believed to move outward (away from the 
central pore) during the depolarizing stage (Guy and Durell 1995). The quaternary 
structure is established when the pore forming  subunit binds to one or more  
subunits. Additional quaternary arrangements of the Na+ ion channels vary depending 
on the binding of the  and  subunits to various other proteins that determine 
membrane localization, voltage sensitivity and connectivity (Gurnett and Campbell 
1996).  
7 
 
In mammals, the voltage gated Na+ ion channel gene family is composed of 10 
distinct  subunit SCN genes (SCNxA) and 4 distinct β subunit genes (SCN1B-SCN4B) 
(Yu and Catterall 2003; Goldin 2001; Catterall et al. 2005). Genes scn5Laa and 
scn5Lab are highly similar to mammalian SCN5A gene-encoded protein, primarily found 
in cardiac tissues (Rogart et al. 1989). The expression of scn5Laa and scn5Lab are not 
just limited to cardiac tissue but are also found in skeletal and nervous system. 
Moreover, biochemical and physiological evidence suggests that zebrafish sodium 
channel genes are likely to be conserved in function and structure with mammalian 
sodium channel genes (Baker et al. 1997; Ribera and Nusslein-Volhard 1998; Tsai et al. 
2001; Warren et al. 2001). According to Chopra, scn5Laa shows 76.1% identity and 
82.8% similarities with scn5Lab and both of these genes show roughly 60% amino acid 
similarities to human SCN5A (Chopra 2008).  
 
Figure 1: Secondary structure of a typical voltage-gated sodium channel (from 
Chopra, 2008) Voltage-gated sodium channels are comprised of 4 homologous 
domains, each with 6 membrane-spanning segments.  Among the functionally-important 
regions of the channel are the S4 voltage sensors (red), which have basic residues at 
every third position and act to transduce changes in membrane potential into movement 
of the channel; the pore loops (blue), comprised of the linkers connecting the S5 and S6 
transmembrane segments within each domain and which contain the channel’s 
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selectivity filter (D-E-K-A); the fast inactivation gate (orange), which is the intracellular 
linker connecting domains III and IV that acts to plug the ion permeation pathway after 
depolarization; and the C-terminus (green), which has calcium-binding EF hand 
structures and motifs for interaction with diverse proteins.  
 
  
 
Figure 2: Exon/intron structure of scn5Laa located on chromosome 2 (Accession 
#DQ149507) Vertical lines in darker green color represent exons. The region between 
each exon represents introns. The arrows represent the direction from the start of the 
exon to the end of the exon.   
 
 
 
 
Figure 3: Exon/intron structure of scn5Lab located on chromosome 24 
(Accession #DQ149508) Vertical lines in darker green color represent exons. The 
region between each exon represents introns. The arrows represent the direction from 
the start of the exon to the end of the exon.  
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Functional Redundancy of Gene Paralogs 
Phylogenetic evidence suggests that scn5Laa and scn5Lab are gene duplicates 
that likely arose from a single ancestral gene as part of a whole genome duplication 
event that occurred early in teleost evolution. Gene duplicates that have diverged 
evolutionarily can express functional redundancy, either complete or partial, as 
mutations accumulate and drive the protein products to divergent but overlapping 
function. This process of divergence with retention of overlapping function is referred to 
as subfunctionalization, a process that has been documented for duplicate gene 
paralogs (Lambert et al. 2015; Kawaguchi et al. 2013). Overlapping expression patterns 
of scn5Laa and ab during embryonic development of the heart are indicative of 
subfunctionalization and suggest that these two genes may act together to specify 
normal heart development.  In addition to the likely possibility that scn5Laa and ab are 
functionally redundant, there is evidence that members of the Na+ channel protein 
family are related and have overlapping subfunctions (Watanabe et al. 2000). 
Depending on the extent of functional redundancy expressed by scn5Laa and ab, it is 
possible that knocking out either scn5Laa or scn5Lab alone might not produce the 
defective developmental cardiac phenotype observed by Chopra et al. following MO 
knockdowns (Chopra et al. 2010).  
A comparison of the exon-intron structure of scn5Laa and scn5Lab shows that 
they are 76.1% similar in identity and 82.8% in similarity (Chopra 2008). Further 
comparisons of amino acid sequences of scn5Laa and scn5Lab shows that they are 
highly similar in the domains that encode transmembrane region and ion channels. Six 
(S1-S6) transmembrane regions (Marban et al. 1998; George Jr. 2005; Roden et al. 
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2002) span each of the four domains (I-IV) in both scn5Laa and ab. Specifically the S4 
transmembrane region plays an important part in action potential. In both of these 
genes, transmembrane segments S5 and S6 contains a pore loop (Figure 1) that acts 
as a selectivity filter (Chopra 2008). The inactivation gate is located intracellularly and 
linked between domains III and IV. The extracellular loop between domain I and II are 
coded by exons 9 and 10 of both scn5Laa and scn5Lab; whereas, the extracellular loop 
between loop II and III are coded by exons 14 and 15 of both scn5Laa and ab (Novak et 
al. 2006). These extracellular loops play a role in ion permeable pathways during the 
depolarization stage.  
Human SCN5A alleles: Correlation with heart defects 
SCN5A found in humans and other mammals is highly expressed in mature 
myocardium and is required for cardiac contractions. Mature SCN5A mRNA product 
contains 28 exons (Wang et al. 1996). Evidence reported in the literature shows that 
mutation in SCN5A leads to various cardiac diseases such as Brugada syndrome, long 
Q-T syndrome (LQTS), atrial standstill, congenital sick sinus syndrome, progressive 
cardiac conduction system, and sudden infant death syndrome (SIDS) (George Jr. 
2005; Koopmann et al. 2006). Rare mutations found in SCN5A can disrupt cardiac 
arrhythmia and lead to Brugada syndrome, LQTS and eventually sudden cardiac death 
(SCD) (Marban 2002; Vincent 1998). SCD was the leading cause of mortality in The 
United States in 1998 causing 300,000 deaths (Zipes and Wellens 1998). 
Brugada syndrome is usually inherited from families in autosomal dominant 
manner and is caused by missense, nonsense, splicing, and frameshift mutations 
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throughout SCN5A coding regions. SCN5A mutation causing Brugada syndrome is 
perceived by right bundle branch block which causes loss of sodium channel function in 
mutant channels to the cell membrane leading to reduction is sodium channel 
availability and trafficking (Wang et al. 2000; Balser 1999; Valdivia et al. 2004; Herfst et 
al. 2004). Evidence of the literature suggests that a G-to-T missense mutation at 
position 4372 was predicted to change the amino acid glycine for an arginine (G1406R) 
between the S5 and S6 transmembrane segment of DIII domain (Kyndt et al. 2001). 
Patients evaluated with this missense mutations showed cardiac conduction defects 
and Brugada phenotype, which required cardioverter-defibrillator implants in one patient 
(Kyndt et al. 2001). Furthermore, another patient with missense mutation leading to 
substitution of a valine instead of a glycine (G352V) coding for transmembrane segment 
S5 and S6 in domain DI led to Brugada syndrome (Vatta et al. 2002). A 20 bp deletion 
in exon 5 of SCN5A, which codes for part of transmembrane S2 and S3 of DI was also 
linked to Brugada phenotype (Vatta et al. 2002). In addition, substitution of amino acid 
lysine by glutamic acid (K126E) at DI-S1 boundary in the intracellular loop was also 
connected to Brugada syndrome (Vatta et al. 2002).  
Similar missense mutations leading to substitution of arginine to histidine 
(R689H) resulted in a loss of function even in heterozygous individual leading to both 
Brudaga syndrome and LQTS (Hong et al. 2012). LQTS represents longer Q-T interval, 
frequent syncope, and SCD due to tachycardia (Moss 2003) and is known to be linked 
to defects in SCN5A and other ion regulating genes (Wang et al. 1995; Mohler et al. 
2003). LQTS can lead to sudden death syndrome in a healthy heart. SCN5A missense 
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mutations linked to the non-synonymous amino acid substitution leading to R1193Q, 
N1325S, R1644H occur in LQTS patients (Wang et al. 2004).  
Transgenic studies in mice with targeted deletion in the SCN5A gene lacking 
sequences coding for amino acid residues 1505-1507 (KPQ) and separate experiments 
that knockouts in LQTS mutant alleles from the human SCN5A gene both showed 
polymorphic ventricular arrhythmias and slow conduction, ventricular tachycardia, sinus 
node dysfunction, increased refractories, respectively (Nuyens et al. 2001; Papadatos et 
al. 2002; Lei et al. 2005). These studies further reported embryonic lethality of the 
homozygous mice with targeted deletions suggesting an important role of SCN5A in 
cardiac development. Furthermore, these studies reported that heterologous expression 
of SCN5A mutation leading to LQTS do not inactivate sodium channel but rather leads 
to sustain depolarization stage during plateau phase of action potential (Wang et al. 
1996; Keating 1996; Dumaine et al. 1996). This evidence suggests that mutation in 
SCN5A leads to reduction in sodium current which might increase sodium channel 
blocking arrhythmia (Pu et al. 1998; Liu et al. 2002; Balser 2001; Viswanathan et al. 
2001; Shimizu et al. 2000).   
A recent study reporting the construction of transgenic zebrafish bearing an 
integrated copy of the human Scn5a-D1275N allele gene showed that the fish 
developed bradycardia, conduction system abnormalities, and pre mature death even 
though these fish carried wild-type alleles for scn5Laa and ab (Huttner et al. 2013). 
These findings suggest that SCN5A can act as a dominant negative gene since 
expression of human Scn5a-D1275N allele lead to defective cardiac function and 
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embryonic death even in the presence of wild-type scn5Laa and scn5Lab (Huttner et al. 
2013).  
TALENs and CRISPR-CAS9 Genome editing: scn5Laa and ab gene knockouts  
TALENs are novel proteins that are used in gene editing to target specific DNA 
sequences for introduction of sequence-specific mutations by inducing sequence-
specific double strand breaks (DSBs).  The DSBs generated by the action of TALENs 
proteins commonly generate insertion or deletion (indel) mutations through the action of 
an endogenous cell non-homologous end joining (NHEJ) DNA repair mechanism (Cade 
et al. 2012). TALENs are composed of a non-binding non-specific Type IIS FokI 
endonuclease domain fused to a highly conserved DNA binding domain derived from 
transcription activator-like (TAL) effectors (Cade et al. 2012). The highly conserved DNA 
binding domain is composed of repetitive 33-35 amino acid repeats. Evidence from the 
literature states “Individual TALE repeats in an array specifically bind to a single base of 
DNA, the identity of which is determined by two hypervariable residues typically found at 
positions 12 and 13 of the repeat” (Joung and Sander p.50). Thus, variable di-residues 
at positions 12 and 13 determine the nucleotide base a particular TALE repeat-will bind 
to and target for FokI endonucleolytic cleavage. For example, asparagine (N) and 
glycine (G) at the position 12 and 13 of the repeat variable di-residue (RVD) is known to 
target the nucleotide thymine as shown in Figure 4. Similarly, at position 12 and 13, di-
residues histidine (H) and aspartic acid (D), asparagine (N) and isoleucine (I), 
asparagine (N) and asparagine (N) target nucleotides cytosine, adenine, or guanine, 
respectively (Figure 4). Since TALENs function as dimers, assembling TALENs requires 
construction of a forward TALE binding site, a spacer region, and a reverse TALE 
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binding site (Huang et al. 2011). Usually, left and right binding sites of the TALENs are 
from 16-21 nucleotides long and the spacer region ranges from 14-17 nucleotides in 
length (Dahlem et al. 2012).  When TALENs bind to the targeted sites, they induce DNA 
double-stranded breaks into the spacer region via the action of FokI restriction 
endonucleases activity that is expressed as a fusion protein with each TALENs.  
Genomic target sites for TALENs-induced DSB breakage are mostly chosen closer to 5’ 
end of the gene sequence with the intention of inducing indel mutations that will result 
in-frameshift mutations early in the coding sequence.  Frameshifts early in the gene’s 
mRNA coding sequence increase the probability of generating translational terminators 
that result in substantial reduction or complete inactivation of the protein’s function 
(Dahlem et al. 2012). TALENs are used in this study because the RVDs can be 
assembled to target any sequence starting with 5’ T, which provides considerable 
latitude in targeting gene sequences (Cade et al. 2012; Reyon et al. 2012).  
 
 
 
Figure 4: 34 Aminoacid repeats. Position 12 and 13 show variable di residues 
Note: Diresidues NN also has specificity for A along with G. This can create a major 
problem for binding specificity.  
 
http://www.genome-engineering.org/taleffectors/ 
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Sequence-specific genome editing can also be achieved using the CRISPR-
CAS9 editing system. The type II CRISPR-CAS9 system is composed of Cas 9 
endonuclease, two small RNAs called CRISPR-CAS9 RNA (crRNA) and trans-
activating CRISPR-CAS9 RNA (tracrRNA). A recent study discovered that a single 
guide RNA (gRNA) can substitute for the crRNA:tracrRNA complex  and recruit Cas 9 
protein to the target site on DNA (Jinek et al. 2012). Because gRNA can recruit Cas 9 
protein to specific target sites on DNA, the only customized component needed for 
induction of double stranded DNA breaks is gRNA. Thus, the CRISPR-CAS9 system is 
simple, more cost effective, less time consuming and more efficient in the generation of 
germ-line mutations compared to TALENs. The CRISPR-CAS9 target site is optimally 
23 bp long (Figure 5). The gRNA can be designed toward any target sequence provided 
that the sequence conforms to the following general structure 5’-GG-N18-NGG-3’ (Jao 
et al. 2013). As a result, it is relatively simple to design gRNA complementary to any 
sequence starting with 5’-GG and ending with PAM sequence (NGG) (Hwang et al. 
2013).  
 Both TALENs and CRISPR-CAS9 genome editing were used to create 
sequence-specific knockouts within both zebrafish scn5Laa and ab genes to determine 
whether these genes individually play a role in the specification of embryonic heart 
development as concluded by Chopra et al. based on the result of MO knockdown 
experiments (Chopra et al. 2010)  If zebrafish scn5Laa and ab function in specification 
of embryonic heart development, then we hypothesized that TALENs and CRISPR-
CAS9 generated knockout mutant null alleles will show developmental phenotypic 
defects that mirror those by resulting from independent MO-induced knockdown of 
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these genes. Further, based on defective heart function and premature death 
phenotype of a zebrafish transgenic line with a stably integrated allele of the human 
SCN5A gene that predisposes humans to cardiac defects and premature death, we 
further hypothesized that zebrafish scn5Laa or ab knockouts may exhibit embryonic 
lethality even in a heterozygous condition. 
 
 
Figure 5: Schematic diagram of CRISPR-CAS9 system containing Cas 9 and 
crRNA:tracrRNA (Jao et al. 2013)gRNA attract Cas9 endonuclease to the targeted 
site. Cas9 induces DNA double stranded breaks 3 bp upstream of PAM sequence.
CHAPTER 2: METHODS 
TALENs-based genome editing mutagenesis 
 Nucleotide sequences of the scn5Laa and scn5Lab genes were obtained from 
NCBI (“Using Pubmed”) using accession numbers DQ149507 and DQ149508, 
respectively. The sequences of exons for these genes were found using Ensemble 
genome browser (Kersey et al. 2013). For scn5Laa, the TALENs target site was located 
in exon 7. The forward targeted site was 17 base pairs (bp) long consisting of 
nucleotides CAGTGTCTTCGCTCTGA; similarly, the reverse targeting site was also 17 
bp long containing nucleotides GTCTCAGGATCCCCATG. The spacer region between 
the forward and reverse TALENs targeting sequences was 16 bp long 
(TCGGTCTGCAGCTCTT). For scn5Lab, the TALENs target site was located in exon 5. 
The forward, 17 bp target site contained nucleotides CCTGGCGCGGGGTTTCT; 
whereas, the reverse, 19 bp nucleotides were TCCAGGGGTCCCTCAGAAA. The 
spacer region was 17 bp long containing nucleotides GCATCGGGCCCTTCACA. To 
construct RVDs (repeat variable di-residues) the following steps were used.   
 Initially, five different single unit vectors (pMD18T) called pA, pT, pG, pC, 
corresponding to RVD NI, NG, HD, NN were used to provide individual repeats (Huang 
et al. 2011). The size of the single unit vector was 2807 bp as shown in Figure 6. In 
order to construct vectors containing RVDs in a particular order and number, repeated 
digestion/ligation cycles were used. For example, to construct RVD pA and pT joined 
together, pA and pT were double digested together with restriction enzymes shown in 
Table 1.  pA was treated as a vector and pT was treated as an insert (Huang et al. 
2011). The samples were incubated at 37°C for 2-4 hours to allow complete digestion. 
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Gel extraction was used to obtain digested pA and pT (note: 1% agarose gel was used 
unless otherwise specified). The QIAquick gel extraction kit and protocol was used to 
purify digested and electrophoresed DNA from both the digested vector and insert. 
Next, pA and pT DNA were ligated by using the reagents shown in Table 2 and 
incubated at room temperature for 30 minutes to 1 hour (Figure 7) (Huang et al. 2011). 
After ligation, 5 l of ligation mixture was used to transform 50 l of DH5α E. coli 
competent cells (Note: DH5α E. coli competent cells were used for transformation 
process in this entire experiment). A total 55 l of the competent cells plus ligation 
mixture was incubated on ice for 30 minutes, then the sample was “heat shocked” at 
42°C for 90 seconds. Immediately after the heat shock, the sample was transferred 
back to ice for 2 minutes. Then 250 l of LB/AMP was added to the ligation mixture. The 
Eppendorf tube containing heat shocked E. coli treated with ligation mixture was then 
shaken at 37°C at 225 rpm for 45 minutes to 1 hour. The competent cell suspension 
was plated on an LB/AMP plate and incubated at 37°C for a minimum of 12 hours 
(Huang et al. 2011).   
 Recombinant DNA containing clones were assayed for inserts by PCR based 
screening using the reagents shown in Table 3. PCR amplification of DNA extracted 
from recombinant containing clones was conducted for 30 cycles. Primers M13-47 and 
RV-M corresponding sequences 5’-CGCCAGGGTTTTCCCAGTCACGAC-3’, and 5’-
AGCGGATAACAATTTCACACAGGA-3’, respectively were used for PCR (Huang et al. 
2011). The PCR product was electrophoresed on a gel to visualize positive clones by 
using a reference marker of 204bp for 2 unit assembly. Transformants containing 
inserts with the correct number and orientation of repeat sequences were grown in ~7-8 
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ml of LB/AMP at 37°C for 19-22 hours at 275 rpm in order to prepare a sufficient 
quantity of DNA for subsequent cloning. Plasmid DNA was purified from cells using 
QIAprep spin miniprep kit according to the manufacturer’s protocol. In order to add 
additional RVD repeats, the procedure above was repeated by adding dimer repeats to 
the existing backbone using the appropriate inserts until the complete number and order 
of TALE repeats with the correct targeting sequence was achieved (Figure 8) (Huang et 
al. 2011). The fully constructed molecule was designated pMD-TALE plasmid.  The 
sequence of the completed insert was verified by sequencing using the same primers 
used for PCR (M13-47 and RV-M) (Figure 9). 
 RVD repeats were cloned into pCS2-FokI (Figure 10) plasmid vectors including 
pCS2-PEAS (to generate left binding site) and pCS2-PERR (to generate right binding 
site) (Huang et al. 2011) and the FokI-TALENs fusion gene. Both pCS2-PEAS and 
pCS2-PERR plasmids were digested with NheI (to linearize) and de-phosphorylated 
after digestion (Huang et al. 2011). pMD-TALE plasmid (treated as an insert) was 
double digested  with SpeI and NheI (Figure 11) and ligated to either the pCS2-PEAS or 
pCS2-PERR vector. Ligation products were transformed into DH5α E. coli competent 
cells as described above and the cells were plated on LB/AMP plates and incubated 
overnight. After selection of recombinant clones, cultivation, plasmid DNA extraction 
and purification, the TALE repeat sequence and orientation in the vector was confirmed 
via sequencing by using SP6 primer. The final constructed plasmids were designated 
PEAS-TALENs and PERR TALENs for forward and reverse TALENs targeting sites, 
respectively.  
20 
 
 For in vitro transcription of the TALENs-FokI fusion gene in the plasmids PEAS-
TALENs and PERR-TALENs for both scn5Laa and scn5Lab, NotI was used to linearize 
the plasmid, DNA was purified using a QIAprep column, and transcribed using a 
mMESSAGE mMACHINE SP6 kit.  The transcribed mRNA was purified from the 
transcription reaction using RNeasy mini kit according to the manufacturer’s protocol.  
 After successful in vitro transcription, zygotes or two cell embryos were 
microinjectioned with 500 pL to 1 nL of mRNA at a concentration of 300pg/nl at an 
injection with pressure (of the gas tank)13 psi, along with adjusting manually on 
microinjector apparatus Model PV 820 Pneumatic PicoPump (World Precision 
Instruments). At 48hpf after microinjections, DNA was extracted from 30 (WT and 
mutated) embryos by treating the embryos with 100 l of 50mM NaOH solution for 30 
minutes.  The solution containing DNA was neutralized by adding 10l of 1M Tris. PCR 
was performed on NaOH-extracted DNA using primers directed toward the target site 
on genomic DNA. After amplification, the presence of indel mutations was scored by 
digesting the PCR product using a restriction enzyme with a cleavage site unique to the 
spacer region of each gene, either scn5Laa  or  scn5Lab (see Table 4). If there is no 
mutation present, the restriction enzyme would cleave the PCR fragment and to 
generate two separate fragments. However, since mutations alter the sequence of the 
restriction endonuclease cleavage site of the TALENs target, the recognition sequence 
of restriction enzyme would be altered and prevent digestion, resulting in a single 
fragment. Digested PCR amplification products were electrophoresed on a 2% agarose 
gel to screen for mutations (Figures 16 and 17). DNA fragments corresponding to 
restriction enzyme resistant products were gel purified using QIAquick gel extraction 
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protocol and ligated to the pGEM-T vector from Promega (Table 5). The ligation 
reaction was incubated at room temperature for ~1 hour before transformation.  After 
ligation, 5 l of the ligation reaction was used to transform 50 l of competent DH5α 
E.coli cells using the same procedure as above except the LB/AMP plate was also 
plated with 100 l of IPTG and 20 l of X-Gal for blue white screening. Plated 
competent cells were grown overnight for at least 12-13 hours in a 37°C incubator. 
Between 8-10 recombinant clones were selected to grow in 7-8 ml LB/AMP broth 
medium for 19-20 hours in the shaker at 37°C and 275 rpm. Plasmid DNA from these 
cultures was purified using QIAprep column as described above and the DNA samples 
were sequenced using the T7 primer to screen for mutations.  
CRISPR-CAS9 System-based genome editing mutagenesis 
 CRISPR-CAS9 target sites (GGN18GG) for scn5Laa and scn5Lab were 
identified by locating a PAM sequence at the 3’ end of the total 23bp target sequence. 
Using this approach, targeted sequences were identified in exons 5 and exon 2, 
respectively.  The sites chosen were GGATTTCAGTGTCATCGTCATGG and 
GGCAGCCATACTGTTTCCACCGG for scn5Laa and scn5Lab, respectively. Forward 
and reverse oligonucleotides were obtained from Sigma Chem Co. (St. Louis, MO). 
Forward and reverse oligonucleotides were phosphorylated and annealed using the 
conditions shown in Tables 6a and 6b.  
 pT7-gRNA vector (“Chen and Wente Lab”) was linearized by digesting with 
BgIII and SaII overnight at 37°C using the reagents shown in Table 7a. Then the 
digested product was purified using a QIAgen Column according to the manufacturer’s 
instructions. Purified product was digested with EPSI (BsmBI) overnight at 37°C using 
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the conditions shown in Table 7b.  One l of product was electrophoresed on a 1% 
agarose gel to verify linearization. After verification, the reaction was stopped by 
denaturing the enzyme at 80°C for 20 mins, the product was purified using QIAgen kit 
and DNA fragment prepared from annealed oligonucleotides were ligated to pT7-gRNA 
vector by using the conditions shown in Table 8. After successful ligation, E. coli DH5α 
cells were transformed using the same procedure as above. The clones with inserts 
were screened for the correct insert using T7 primer for DNA sequencing.  
 A Cas 9 expression plasmid pCS2-nCas9n, was also obtained from Chen and 
Wente labs (“Chen and Wente Lab”). Prior to transcription the plasmid was linearized  
using NotI and purified using a QIAprep column. Capped RNA were then synthesized 
using a mMESSAGE mMACHINE kit and purified using an RNeasy kit (Qiagen) 
according to the manufacturer’s instructions (Jao et al. 2013). The mix of Cas 9 RNA 
(100-300 pg/embryos) and gRNA (7-30 pg/embryos) were microinjected into the one-to-
four cell stage embryos. Between 500-600 embryos were injected per gene.  
 About 48 hours after microinjections, 30 randomly selected embryos were 
screened for mutations. DNA was extracted from these 30 embryos by treating with 100 
l of 50mM sodium hydroxide solution. The amplified PCR product was purified using 
QIAgen PCR purification kit and purified PCR product was screened for mutations with 
the T7 endonuclease assay.  The T7 assay is comprised of two stages: a 20 minutes 
hybridization reaction followed by a 15 minute T7 endonuclease digestion reaction. The 
initial stage of the hybridization reaction denatures double strand of DNA and is 
conducted at 98°C. During the later stage of hybridization reaction, which is conducted 
over a ramp temperature from 98 to 55°C, complementary strands anneal with one 
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another. Hybridization reactions were conducted by using the Master Cycler Gradient 
thermal cycler (Eppendorf 5331) condition shown in tables 9a and 9b. The hybridization 
mixture was then digested by T7 Endonuclease at 37°C for 15 minutes. T7 
endonuclease is known to cleave double-stranded DNA at mismatched bases. After 15 
minutes of incubation, the digestion reaction mixture was stopped by adding 1l of 
0.25M EDTA. The sample was immediately electrophoresed on a 1% agarose gel. If the 
bands on the gel showed any sign of mutation, then we proceeded with cloning and 
sequencing to verify the mutation. For cloning, PCR product of the sample was ligated 
to pGEM-T vector by using the reagents shown in Table 5. Ligated DNA samples were 
transformed and screening for inserts using the same protocol described under the 
Methods section “TALENs-based genome editing mutagenesis.”  
Screening F0, F1, F2, and F3 Generations for scn5Laa and ab mutations 
 After bulk screening, the remaining embryos were raised and screened for 
specific mutations in scn5Laa and ab genes. When these embryos (F0 generation) 
reached sexual maturity, each individual injected fish-was mated with wild-type (WT) 
fish in order to generate F1 generation embryos. After 48hpf, about 30 F1 embryos from 
each injected F0 fish were screened for germ-line mutation by following the same 
procedure as above. If these embryos carried germ-line mutations from a specific F0 
individual, then the rest of the F1 embryos from a particular F0 mutant were raised to 
adulthood for individual screening after reaching adulthood.  
 Once embryos from the F1 generation reached adulthood, each fish was 
screened for heterozygous mutation using the mutation screening assay described in 
Methods. Briefly about 20 mg of fin tissue was removed from the caudal fin by clipping it 
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off with a pair of fine scissors after anaesthetizing the fish with MS-222 (100 g/ml for 1-
2 minutes). The fin clip tissue was immersed in 50l of 50mM sodium hydroxide solution 
to dissolve the tissue and extract DNA. The screening procedure for the F1 generation 
fish was exactly the same as above bulk screening procedure of the embryos. When at 
least one heterozygous mutation-bearing male and a female were identified through 
DNA sequence verification, were mated with each other to produce F2 generation 
embryos. Based on Mendelian principles of inheritance, 1/4th of these embryos were 
expected to be homozygous mutants in which both alleles were knocked out for either 
scn5Laa or scn5Lab. Once F2 generation embryos reached adulthood, individual fish 
were screened as described in methods to identify homozygous mutants. After 
homozygous mutants were verified via sequencing, a male and a female mutant were 
mated with each other to produce a fully homozygous F3 generation. All the embryos in 
the F3 generation of both scn5Laa and scn5Lab mutants were homozygous for the 
mutant alleles. Phenotypes of F3 generation embryos were observed and compared 
with wild-type embryos using stereomicroscope at 10 and 20X magnification. F3 
generation and WT embryos were closely monitored under microscope starting 24 hpf 
for potential phenotypes such as gross pericardial edema, yolk-sac edema, reduced 
heart rate, and progressive thinning of the heart. If these phenotypes were evident in 
mutant embryos compared to WT embryos, mutant embryos were screened using 
sequencing for homo allelic mutation. If the F3 generation embryos did not show any 
defective cardiac phenotypes, random 20 embryos were screen to verify the homo 
allelic mutation in the expected region.  
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Additional Microinjections to Identify the Nature of Putative scn5Laa Mutants 
 Due to certain unexpected results of scn5Laa knocked out fish, additional 
microinjections were conducted to test a hypothesis that scn5Laa might be expressed 
as a dominant negative gene, with the potential to induce heart defects and lethality in 
F0 embryos and larval fish. Three different trials of microinjections were conducted in 
which between 300-400 embryos were microinjected with either scn5Laa gRNA or a 
control gRNA. For the control group, gRNA other than scn5Laa gRNA were used to 
control for lethality or gross morphological defects unrelated to scn5Laa or ab gRNA. 
For both gRNAs and Cas9, the same microinjection conditions-as described in Methods 
were used. Death rates and phenotypes of the F0 microinjected embryos from both 
groups were observed and compared.  
 
Physiological and Developmental Characterization of scn5Laa and ab Knockout 
Mutants 
Since zebrafish embryos and early stage larvae are optically clear, scn5Laa and 
scn5Lab knockout lines (heterozygous and homozygous mutants) were compared to 
wild-type controls by measuring their heartbeat rates at selected times during 
development. Both mutant and wild-type zebrafish were spawned around 9:00 am and 
the embryos were harvested anytime up until 1:00 pm. After 24 hpf (when the heart is 
first visible under a microscope), 3-5 embryos from control and mutation-bearing groups 
were dechorionated and embedded in 1% low melting point agarose prepared in stock 
zebrafish water on a microscopic slide. The embryos and larvae were observed under 
the stereomicroscope at 10 and 20X magnification at timed intervals post-spawning to 
determine if stereotypical heart developmental defects like gross pericardial edema, 
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reduced heart rate and progressive thinning of the heart were evident. Embryo and 
larval heart beat rate was measured by manually counting heart beats for 1 minute time 
intervals at three consecutive periods at each time point for each embryo. Heart beats 
of both control and mutant embryos were counted every two hours from 24 to 30 hpf. 
Heart beat rates were measured again for embryos that were 48 hpf for a period from 
48 hpf to 54 hpf using the same procedure described above. These experiments were 
repeated three times from independently spawned embryos. We counted heartbeats of 
heterozygous and homozygous mutation-bearing embryos and compared them to each 
other and WT embryos. Statistical t-tests were conducted to determine whether there 
was a significant difference in the heartbeat rates of control group compared to mutants 
at each sample time. Scn5Laa homozygous knockouts were compared statistically and 
physiologically to scn5Laa heterozygous knockouts, scn5Lab homozygous knockouts 
and WT embryos. Similarly, scn5Lab homozygous knockouts were compared 
statistically and physiologically to scn5Lab heterozygous knockouts and WT embryos.  
 
 
 
 
Vector Volume (l) 
10X Tango Buffer 2.0 
NheI 0.8 
HindIII 0.8 
pA (plasmid DNA) 16.4 
Total 20.0 
 
Table 1: Reagents used for DNA restriction endonuclease digestion of vector and 
insert for RVD construction of TALENs 
 
 
 
 
 
Insert Volume (l) 
10X Tango Buffer 2.0 
SpeI 0.8 
HindIII 0.8 
pT (plasmid DNA) 16.4 
Total 20.0 
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Ligation Volume (l) 
5X T4 DNA Ligase buffer 2.0 
Vector 1.0 
Insert 6.9 
T4 DNA Ligase 0.1 
Total 10.0 
 
Table 2: Reagents used for DNA ligation of vector and insert for RVD construction 
of TALENs 
 
 
 
 
 
Reagents Volume (l) 
Water (SDW) 6.55 
5X Go Taq Buffer 2.0 
Mgcl2 1.0 
dNTPs 0.2 
Fw primer 0.1 
Rv primer 0.1 
DNA Taq Polymerase 0.05 
DNA 1 transformed colony 
Total 10.0 
 
Table 3: Reagents used for PCR clone check to verify ligation of insert to vector 
 
 
 
 
 
scn5Laa Volume (l) 
1X Buffer O  4.0 
PstI 3.2 
Amplified PCR Product 32.8 
Total 40.0 
 
Table 4: Reagents used to check the presence of indel mutation in the spacer 
region between TALENs target sites 
The buffer and enzymes were ordered from Thermo Scientific.  
 
 
 
 
 
scn5Lab Volume (l) 
1X Buffer B  4.0 
ApaI 3.2 
Amplified PCR Product 32.8 
Total 40.0 
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Ligation Mixture Volume (l) 
2X Rapid Ligation buffer 2.5 
pGEM®-T or pGEM®-T Easy Vector (50 ng) 0.5 
Gel purified PCR Product 1.5 
T4 DNA Ligase 0.5 
Total 5.0 
 
Table 5: Reagents used for T-vector cloning ligation 
The reagents were obtained from Promega.  
 
 
 
 
 
 
 
Table 6a: Phosphorylation and annealing conditions for oligonucleotides in PCR 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6b: Reagents added to anneal and phosphorylate oligonucleotides 
 
 
 
 
 
 
 
 
 
 
Table 7a: Reagents added for first digestion reaction to linearize pT7-gRNA vector 
 
 
 
 
 
Incubation Time (minutes) 
Incubate at 37°C 30 
Incubate at 95°C 5 
Ramping down to 25 °C at 5°C/min (0.08 °C/sec)  
Reagents Volume (l) 
sgRNA Oligos Forward (100 m)  1.0 
sgRNA Oligos Reverse (100 m) 1.0 
10X T4 Polynucleotide Kinase (PNK) buffer 1.0 
T4 PNK 1.0 
Water  6.0 
Total 10.0 
Reagents Volume (l) 
pT7-gRNA Plasmid (~202 ng/l) 16.4 
10X OPTIZYME Buffer 3 2.0 
BgIII 0.8 
SaII 0.8  
Total  20.0 
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Reagents Volume (l) 
Purified pT7-gRNA Plasmid  30.0 
10X OPTIZYME Buffer 4 4.0 
DTT (20mM) 2.0 
EpsI (BsmBI) 3.2  
Water   0.8 
Total 40.0 
 
Table 7b: Reagents added for second digestion reaction to linearize purified pT7-
gRNA vector 
 
 
 
 
Reagents Volume (l) 
2X Rapid Ligation Buffer  2.5 
Linearized  pT7-gRNA Vector 1.0 
Diluted Oligos (1:200) 1.0 
T4 DNA Ligase 0.5  
Total 5.0 
 
Table 8: Ligation of oligonucleotides to pT7-gRNA Vector 
 
 
 
 
Reagents Volume (l) 
NEB Buffer 2  1.0 
Purified PCR product 8.5 
Table 9a: Conditions for T7 Endonuclease Assay 
 
 
 
 
Incubation Time (minutes) 
Incubate at 95°C  5 
Ramp Down to 85°C at -2°C/s  
Ramp down to 25 °C at -1°C/s   
Final Hold at 4°C  
 
Table 9b: Condition for Hybridization Reaction in Thermal cycler 
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Figure 6: The representative plasmid structure of the single unit vectors for 
TALENs-TALE synthesis (Huang et al. 2011) 
 
 
 
 
 
Figure 7:  Schematic Diagram showing steps in the construction of vector pAT 
recognizing nucleotide sequences of 5’-AT-3’ (Huang et al. 2011)  
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Figure 8: Schematic Diagram showing the construction of pMD-TALE vector with 
multiple TALE repeats (Huang et al. 2011) The assembly of the TALE repeats for the 
left TALE binding site of tnikb gen 
 
 
 
 
 
 
 
 
 
 
32 
 
 
Figure 9: The representative plasmid structure of pMD-TALE vectors (Huang et al. 
2011) 
 
 
       
 
Figure 10: The representative plasmid structure of pCS2-FokI vectors (Huang et 
al. 2011) 
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Figure 11: Schematic diagram for the construction of pCS2-TALEN vectors 
(Huang et al. 2011) 
 
 
 
 
 
 
 
CHAPTER 3: RESULTS 
TALENs authentication 
The scn5Laa and ab gene-targeting TALENs were authenticated by a 
combination of restriction endonuclease mapping and direct DNA sequencing. After 
assembly and cloning of 16 unit TALENs into PEAS-TALENs and PERR TALENs 
(forward and reverse TALE binding sites, respectively) for both scn5Laa and scn5Lab, 
the plasmids (PEAS-TALENs and PERR TALENs) were double digested with NheI and 
KpnI. Based on the DNA sequence of PEAS-TALENs and PERR TALENs plasmids, the 
KpnI restriction site is 441bp upstream of NheI restriction site on pCS2-FokI vector 
(Huang et al. 2011). The total size of the vector backbone pCS2-PERR was 5458bp. 
The total size of 16 unit assembly for TALENs target site was 1632bp. If the insert is in 
the forward orientation, the clone is predicted to generate fragments of 2073bp (441bp + 
Insert size of 1632bp) and 5017bp (vector size – 441bp) after double digestion with 
NheI and KpnI (Figure 12-lane 11). Figure 12 shows a gel image of 16 unit insert 
ligation to PERR-TALENs plasmid for the scn5Laa reverse site. There is a possibility of 
this insert to ligate into the reverse direction to the vector. If the insert is in the reverse 
direction, the fragments are predicted to be 441 and 7090 (Figure 12-lane 13). If the 
vector self-ligated without insert in it, the prediction is for fragments of 5017 bp and 441 
bp (Figure 12-lanes 2, 10, 12). Since 441 bp is significantly smaller than other bands, 
they were predicted to travel faster on the gel and are not readily visible. Lanes 3, 4, 5, 
and 9 of Figure 12 represents clones containing just inserts that did not successfully 
ligate to the pCS-PERR vector. As shown in Figure 12, only lane 11 showed bands at 
5017bp and 2073bp, which is indicative of an insert in the correct (forward) orientation. 
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Based on this information the PERR-TALENs plasmid insert from the E.coli clone 
representing lane 11 was sequenced using the SP6 primer to verify orientation and 
sequence of the insert. Sequence analysis verified that the clone referred to as scn5Laa 
PERR-TALENs #11 contained an insert in the forward direction representing a 16 unit 
TALENs assembly designed to target nucleotides GTCTCAGGATCCCCATG.  
The same approach was used to verify the orientation and sequence of inserts 
for scn5Lab PEAS-TALENs and PERR-TALENs plasmids. Figure 13 shows a gel image 
of 16 unit insert ligation to PEAS-TALENs plasmid and 18 unit insert ligation to PERR-
TALENs plasmid for the scn5Lab forward and reverse TALENs target site, respectively. 
For scn5Lab, the 16 unit assembly for the forward TALENs binding site (PEAS-
TALENs) had an insert of 1632 bp; whereas, the 18 units assembly for reverse TALENs 
binding site (PERR-TALENs) had an insert of 1836 bp. Lanes 1-11, 13, 14, and 19 in 
Figure 13 represent bands from the double digestion with NheI and KpnI of PEAS-
TALENs plasmid of scn5Lab. Lanes 12, 15-18, 20-28 in Figure 13 represent bands from 
the double digestion with NheI and KpnI of PERR-TALENs plasmid of scn5Lab. The 
clones with inserts in forward orientation for PEAS-TALENs site produced bands at 
5017 bp and 2073 bp (Figure 13-lanes 13, 14, 19). The clones with inserts in reverse 
orientation produced bands at 7090 bp and 441 bp (Figure 13-lanes 2, 3). Self-ligated 
vector produced bands at 5017 bp and 441 bp (Figure 13-lanes 9, 11). Lanes 1, 6, and 
10 of Figure 13 represent undigested vector producing band at 5458 bp. Since PERR-
TALENs plasmid is composed of 18 units, insert in the forward direction produced 
bands at 2277 bp and 5017 bp (Figure 13-lanes 12, 20, 23, 26). Insert in the reverse 
direction produced bands at 7294 bp and 441 bp (Figure 13-lanes 16, 18, 24, 25, 27, 
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28). Self-ligated vector produced bands at 5458 bp and 441 bp (Figure 13-lanes 15, 17).  
Clone numbers 13, 14 (PEAS-TALENs site) and 20, 23 (PERR-TALENs site) were 
verified for the forward insert orientation via sequencing using the SP6 primer. 
Identification of TALENs-induced mutations in zebrafish  
To confirm the general capability of scn5Laa and ab-directed TALENs to induce 
mutations at their respective target sites in zebrafish embryos after microinjection, about 
30 embryos microinjected with TALENs directed toward scn5Laa or ab genes were 
screened using the bulk screening approach described in Methods. Results from 
digestions of PCR amplification products obtained from DNA extracted from pooled 
TALENs microinjected embryos are shown in Figures 14, 15, 31, 32. Figures 14 and 15 
show gel image and sequencing data from bulk screening of the embryos injected with 
TALENs molecules targeting forward and reverse sites, CAGTGTCTTCGCTCTGA and 
GTCTCAGGATCCCCATG, respectively in exon 7 of scn5Laa. Lane 4 of Figure 14 
shows two bands compared to other bands on the gel. The top band in lane 4 (indicated 
by an arrow) represents product expected if the PstI restriction site was inactivated by 
mutation in the spacer region (TCGGTCTGCAGCTCTT). The top band representing 
undigested mixture was 201 bp long. The second band in lane 4 represents wild-type 
sequence. The digested products are expected to produce two bands at 95 bp and 106 
bp. Since these two bands are approximately the same in size, they overlap on the gel 
showing one broad and relatively intensely staining band instead of two separate bands. 
Bands in lanes one and two of Figure 14 show control samples producing digested 
products. Figure 31 shows a gel image from bulk screening of scn5Lab TALENs-
targeted embryos in exon 5.  Scn5Lab TALENs target site for the forward and the 
37 
 
reverse sites were CCTGGCGCGGGGTTTCT and TCCAGGGGTCCCTCAGAAA, 
respectively. Lane 4 of Figure 31 shows bands that were 361 bp, 310 bp and 104 bp 
long. The 361 bp fragment represents the product expected if the ApaI restriction site 
was inactivated by mutation in the spacer region (GCATCGGGCCCTTCACA), while the 
two fragments at 310 bp and 104 bp in length represents the digestion products of PCR 
products derived from DNA in which the restriction site was unaltered.  Based on these 
results, it was concluded that the TALENs were effective in inducing mutations in the 
spacer region (GCATCGGGCCCTTCACA). However, the exact percentage of embryos 
in which mutations were induced cannot be accurately determined using this bulk 
screening approach. In Figures 14 and 31, the arrow points to an undigested product 
with an additional band at 201 bp and 361 bp, respectively compared to control wild-
type (WT). Additional bands representing mutations in both scn5Laa and scn5Lab were 
cloned and sequenced using the T7 primer. Between 5-8 clones were selected for 
scn5Laa and scn5Lab to sequence. Figures 15 and 32 show the sequencing results for 
clones derived from DNA fragments purified PCR products for either scn5Laa or 
scn5Lab genes, respectively. In Figure 15, clone numbers 1 and 7 show deletions of -
3bp and -8bp, respectively, relative to the wild-type sequence. The 3 bp deletion in 
clone #1 causes an in-frame mutation leading to one missing amino acid. However, 
sequencing data from clone #2 shows an 8 bp deletion that cause a frameshift mutation 
in the coding region. Overall, the data shows that out of 30 embryos screened, one of 
them possess in-frame mutation while the other one is carrying frameshift mutations. 
This data suggests that there is a 50% chance of these embryos showing frame-shift 
mutations once they reach adulthood. Only 60 fish survived and reached adulthood 
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from this batch. Out of these 60, none of them showed any mutation at the targeted 
sequence. Figure 32 shows various mutations for scn5Lab compared to WT including 
+4bp insertion, -13bp deletion, and a single nucleotide polymorphism (SNP). The data 
shows that most of the embryos injected with TALENs scn5Lab mRNA have frameshift 
mutation.  
After the F0 embryos reached sexual maturity, each individual fish was screened 
for germline cell transmission of mutations by mating with WT and examining their 
offspring for the mutant allele in a heterozygous condition. F1 offspring were screened 
for mutations as early as 48hpf.  In the case of scn5Laa-targeted fish only, no germline 
cell transmission of mutations was observed on gels after PCR amplification and 
digestion of DNA prepared from F1 offspring. We screened 60 individual adult fish and 
did not find any mutants. The digested product looked exactly like control wild-type 
product on the gel. By comparison, two scn5Lab F0 males showed germline 
transmission of their respective mutations after screening 75 individual fish. Embryos 
from these mutant males (#3-8 and 5-6) were screened using the same protocol as 
described in methods. Figures 34 and 36 clearly show the additional third band 
(designated by arrows) indicating the undigested product as a sign for mutation. This 
band was gel extracted and sequenced in order to verify the mutation. Figure 35 shows 
the changes in DNA sequence of the mutant #3-8 compared to WT. The sequencing 
result provides evidence for a 5 bp deletion compared to WT strand. Furthermore, 
Figure 35 shows that this frameshift leads to a frame-shift in the amino acid sequence 
compared to WT starting at amino acid 182. In the WT strand, the 182nd amino acid is 
glycine (G); whereas, in the mutant strand the frameshift changed the 182 amino acid to 
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leucine and all amino acids up to the stop codon at 203 were also altered. The normal 
length of the protein product for scn5Lab is 1954 amino acids. Figure 36 shows gel 
image for mutant #5-6. Figure 37 shows changes in the DNA sequences of mutant #5-6 
compared to WT. In this case, there was a 15 bp deletion compared to WT strand which 
caused a five amino acid in-frame mutation. Furthermore, Figure 37 shows that amino 
acids 1-179 are exactly the same as WT. Due to in-frame mutation, amino acids 180-
184 are missing in mutant #5-6 compared to WT protein; however, based on DNA 
sequence the remainder of mRNA and resultant amino acids (185-1954) could be 
translated.  
When F1 generation offspring from mutant #3-8 reached adulthood, about 50 
individual fish were screened and yielded 4 heterozygous TALENs-induced mutants. 
The gel image (Figure 34) and sequencing results of these 4 fish were exactly the same 
as their male parent mutant #3-8. Their hetero allelic mutation had 5 bp deletion 
compared to WT strand which caused a frameshift mutation as shown in Figure 35. 
After sequence verification of the mutation, four F1 heterozygous mutants were mated 
with each other to produce F2 generation offspring. According to Mendelian genetics, 
25% of the F2 generation is expected to have homozygous null mutations for scn5Lab. 
Physiological examination of the F2 generation embryos revealed that 7% of these 
embryos showed abnormal cardiac phenotypes 6dpf as shown in Figure 40. These 
embryos showed significant pericardial edema, yolk-sac edema, and died prematurely. 
These embryos were sequenced to determine if they carried the F1 parent frame-shift 
mutation. The embryos that died prematurely after showing abnormal cardiac and yolk-
sac edema showed homozygous null allele mutation. Surprisingly, when the remaining 
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embryos from this batch reached adulthood, we found additional homozygous null allele 
mutants that were able to develop normally. When we screened 14 of the remaining F2 
generation fish once they reached adulthood, five of them showed homozygous null 
allele mutation. These fish had the exact same frame-shift mutation as the other 
embryos that showed cardiac and yolk-sad edema and ended up dying prematurely. 
Once F2 generation adult fish were sequence verified, we mated those with each other 
to produce F3 generation offspring. As expected, 100% of F3 generation offspring are 
homozygous null allele mutants for scn5Lab. Unfortunately, embryos from these F3 
generation fish did not show us any abnormal developmentally defective phenotypes.  
Identification and characterization of CRISPR-CAS9 Induced Mutants  
Given the absence of TALENs-induced scn5Laa-induced mutations and the 
relatively low number of TALENs-induced scn5Lab-induced mutations, further genome 
editing experiments were conducted using the CRISPR-CAS9 genome editing system. 
Just like TALENs, the screening process was conducted in two stages, a bulk screening 
stage and a single animal screening stage. In the case of CRISPR-CAS9-induced 
mutations, the screening was not conducted by restriction endonuclease digestion of 
PCR product, instead -purified PCR products were screened using the mismatch 
cleavage activity of T7 endonuclease at the CRIPSR-CAS9 target sites. The CRISPR-
CAS9 target site for scn5Laa was GGATTTCAGTGTCATCGTCATGG located in exon 
5. Mutation resulting from CRISPR-CAS9 induction show up as 3 distinct bands on the 
gel. Figure 16 shows a gel image of bulk screening of 30 embryos at 48 hpf for 
scn5Laa. The first band shown in lane 2 of Figure 16 represents undigested product 
after T7 endonuclease digestion. Since T7 endonuclease cleaves at the mismatched 
41 
 
DNA base pair site, the potential bands after the cleavage are supposed to be 462 bp 
and 176 bp, respectively for scn5Laa. However, Lane 2 shows four bands after T7 
assay. The first band is 638 bp long and corresponds in length to the expected 
undigested PCR product. We surmise the second band occurs because of a sequence 
polymorphism. We hypothesize that the second band represent a sequence 
polymorphism in wild-type zebrafish because a band around ~500bp is not expected 
from T7 endonuclease, and since our positive control in lane 3 also shows a band 
around 500 bp, it is believed that T7 endonuclease also cleaved an additional site 
resulting from the naturally occurring polymorphism. The third and fourth bands which 
are 462 bp and 176 bp in length are products expected from T7 endonuclease cleavage 
of the PCR product resulting from mutationally-induced mismatches between wild-type 
sequence and mutation-bearing sequences. Lane 3 shows bands for the positive control 
which has bands at the exact same sizes at lane 2. Lane 4 has a marker for undigested 
control of 638bp which is difficult to visualize in the gel image due to loading dye 
masking the DNA-containing band.  Figure 17 shows sequencing data from the bulk 
screening procedure for verification of the mutation inducing activity of the scn5Laa 
targeting gRNA. 30 embryos were screened from 500-600 embryos that were 
microinjected. Clone #2 shows 5 bp deletion causing a frame-shift in the coding region 
that can result premature translation termination (Figure 17). Clone #5 shows 3 bp 
deletion causing an in-frame mutation compared to WT strand. Data from Figure 17 
suggests that these embryos have a 50% chance of having either frame-shift or in-
frame mutation. It was assumed that a similar proportion of the remaining microinjected 
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embryos would have mutations as well. However, only 8% of these embryos (1/13) 
showed frame-shift mutation once they reached adulthood.  
Consequently, the remainder of the embryos were grown to the adult stage and 
screened for mutations in DNA obtained from fin-clips. Screening 50 individual fish 
revealed 13 potential F0 mutants (see Figures 18-30). The gel images show three 
distinct bands for each of the digested PCR amplification products, a property expected 
for sequences bearing mutations.  However, DNA sequencing results shown in Figures 
18-29 show that deletions present in fish #1, 4, 14, 15, 17, 32, 34, 42, 44, 49, 52, and 
55 resulted in in-frame mutation. However, mutant number 7 (shown in Figure 30) had a 
two nucleotide frameshift which is predicted to prematurely terminate translation after 
amino acid 210 compared to the wild-type protein, which is 1932 amino acids long. 
Mutant #7 was crossed with wild-type to generate F1 heterozygotes. Of 30 adult F1 fish, 
5 were determined to be heterozygote CRISPR-CAS9 induced mutation-bearing fish. 
These mutants were sequence verified to make sure they inherited the same mutation 
shown in Figure 30 from their mother. After sequence verification, these 5 mutants were 
mated with each other to produce F2 generation offspring. Again, 25% of these 
offspring are expected to be homozygous null allele mutants for scn5Laa. We did not 
observe any developmental defective phenotypes when these embryos from these 
crosses were growing. Once the embryos reached adulthood, we screened 37 fish and 
identified 7 homozygous mutants based on DNA sequence analysis of PCR amplified 
and cloned genomic DNA. These homozygous mutants were mated with each other 
after sequence verification to produce F3 homozygotes. 100% of F3 generation 
offspring were expected to be homozygous null mutants. Stereomicroscopic screening 
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of these F3 homozygous mutants did not reveal a higher portion of developmentally 
defective mutants than suitable wild-type controls.  
To determine why scn5Laa embryos had a high percentage of in-frame mutants 
compared to frameshift mutants, we microinjected more WT embryos with scn5Laa 
gRNA and screening for embryonic lethality and induction of developmental defects. We 
conducted independent replicate microinjections trials each one week apart using wild-
type zygotes prepared from different wild-type parents. These embryos scored 
beginning at 24hpf for developmental defects and lethality phenotype. Between 50hpf to 
80hpf we saw the most developmental defective phenotypes including premature death 
of the embryos compared to control injected group. We consistently observed 25-35% 
death during embryonic development for scn5Laa gRNA injected embryos compared to 
5-7% death in the control group. Moreover, 3-10% of the embryos injected with scn5Laa 
gRNA showed developmentally defective phenotypes in each of the three trials but 
none in the control group. Figure 41 shows developmental defects caused by injection 
of scn5Laa gRNA. These defects include cardiac edema, yolk sad edema, curvature of 
spine, and premature embryonic death. Extracted DNA from these embryos were 
cloned in order to determine the genotype of these embryos. Mutations were not 
detected in any of the developmentally defective embryos.  
Heartbeat Rate and Developmental Phenotype Characterization of TALENs and 
CRISPR-CAS9-Incduced scn5Laa and ab Mutants 
Statistical comparison of the differences in heartbeat rate of heterozygous and 
homozygous knockout embryos for either scn5Laa or scn5Lab did not show any 
difference between the heart rate compared to each other or to the WT embryos at any 
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time periods for first three days of development (Table 10), which is the critical time 
period for observing expected heart defects. Figure 42 shows the comparison of 
heartbeat between scn5Laa heterozygous and homozygous embryos with scn5Lab 
heterozygous and homozygous embryos and WT embryos. The bar graphs in Figure 42 
shows that the heart rate of these embryos are very similar to each other at any given 
time period. Moreover, knockouts did not show any significant gross development 
phenotypic differences and were able to grow normally through the larval stage of 
development. We were successfully able to sequence 20 embryos from each batch to 
verify homo allelic mutation. These data suggest that knockout of either scn5Laa or 
scn5Lab individually had no effect on the developmental or physiological characteristic 
of the heart. 
 
 
 
Figure 12: Sixteen unit TALEN assembly for scn5Laa gene reverse target site 
Lanes 1-5 and 9-13 represent fragment patterns from DNA obtained from E. coli clones 
after double digestion (with NheI and KpnI) and electrophoresis of the plasmid PERR-
      1       2       3       4       5       6       7        8     9       10    11      12      13 
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TALENs for scn5Laa. Lane 7 is the 1 kb molecular length standard (Life Technologies). 
Lane 11 represent insert in the forward direction by producing bands at 5017 bp and 
2073 bp. Lanes 13 represent insert in the reverse direction by producing bands at 7090 
bp and 441 bp. Lanes 2, 10, 12 represent vector self-ligating by producing bands at 
5017 bp and 441 bp. Since bands at 441 bp were predicted to travel faster on the gel, 
they are not readily visible. Lanes 3-5 and 9 represent clones containing only inserts.  
 
  
 
Figure 13: Sixteen-eighteen unit TALEN assembly for scn5Lab forward and 
reverse target sites. Lanes 1-6, 9-11, 13, 14, and 19 represent fragment patterns from 
DNA obtained from E. coli clones after double digestion (with NheI and KpnI) and 
electrophoresis of the plasmid PEAS-TALENs for scn5Lab; whereas, lanes 12, 15-18, 
20, 23-28 represents fragment patterns of plasmid PERR-TALENs for scn5Lab. Lanes 
12, 14, 19 represent clones containing insert in the forward direction for PEAS-TALENs 
producing bands at 5017 bp and 2073 bp. Clones in lanes 2 and 3 represent insert in 
the reverse direction producing bands at 7090 bp and 441 bp. Clones in lanes 9 and 11 
represent self-ligating vector producing bands at 5458 bp. Lanes 1, 6, and 10 represent 
undigested sample producing a single band at 5458 bp. Lanes 12, 20, 23, and 26 
represent insert in the forward direction for plasmid PERR-TALENs representing bands 
at 5017 bp and 2277 bp. Lanes 16, 18, 24, 25, 27, 28 represent insert in the reverse 
direction producing bands at 7294 bp and 441 bp. Lanes 15, 17 shows bands for self-
ligating vector at 5458 bp and 441 bp. 
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Figure 14: Gel Image to show scn5Laa F0 Bulk Screening mutation. Lane 1 
represents F0 generation of scn5Laa PCR product digested with PstI with no indication 
of indel mutations producing overlapping bands at 106 bp and 95 bp. Lane 2 represents 
WT digested sample producing overlapping bands at 106 bp and 95 bp. Lane 4 shows 
F0 generation scn5Laa PCR product digested with PstI producing two bands indicated 
indel mutation. The top band is 201 bp long indicated undigested product due to the 
presence of indel mutation. The bottom band is an overlap of two bands (at 106 bp and 
95bp) showing the digested mixture indicating presence of no indel mutations in some 
of the 30 embryos that were screened. 
 
 
 
 
           CAGTGTCTTCGCTCTGATCGGTCTGCAGCTCTTCATGGGGATCCTGAGAC              (WT) 
(1)       CAGTGTCTTCGCTCTGATCGGTCTGCA------CTTCATGGGGATCCTGAGAC              (-3) 
(7)       CAGTGTCTTCGCTCTGATCGGTCT-----------------TCATGGGGATCCTGAGAC              (-8) 
 
 
Figure 15: Sequencing results of scn5Laa Bulk Screening 
The highlighted portion refers to scn5Laa TALENs forward and reverse binding sites 
targeted from plasmid scn5Laa PEAS-TALENs and PERR-TALENs, respectively. Clone 
#1 shows 3 bp deletion compared to WT strand; whereas, clone # 7 represents 8 bp 
deletion compared to WT strand in the spacer region of TALENs targeted site.  
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Figure 16: Bulk screening F0 CRISPR-CAS9 injected embryos for scn5Laa 
Lane 1 represents wild-type PCR amplification product after T7 endonuclease digestion 
showing just a single band at 638 bp. Lane 2 shows PCR amplification product from 
bulk embryo clutch treated with CRISPR-CAS9 RNA after T7 endonuclease digestion 
producing four bands. First band is 638 bp long representing undigested products. 
Second band is for polymorphism since band around 500 bp is not expected. Last two 
bands represent the presence of indel mutation. Cleavage site of CRIPSR RNA is 
predicted to produce bands at 462 bp and 176 bp. Lane 3 shows scn5Laa Positive 
control obtained from a sample known to produce bands corresponding mutation. Lane 
4 represents undigested PCR amplified product from bulk embryos to run as a marker 
for 638 bp.  
 
 
 
 
 
Figure 17: Sequencing results of scn5Laa Bulk Screening 
Highlighted portion refers to 23 bp CRISPR-CAS9 target site for scn5Laa. Clone # 2 
shows 5 bp deletion compared to WT strand; whereas, clone # 5 represents a 3 bp 
deletion compared to the WT strand.  
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Figure 18: scn5Laa gene F0 Mutant #14, in-frame mutation. Mutant # 14-4 shows 6 
bp deletion (in-frame mutation) compared to WT strand. The highlighted portion refers 
to this protein missing isoleucine and valine compared to WT production. The gel image 
shows three bands, at 638 bp, 462 bp, and 176 bp compared to WT strand producing 
only one band at 638 bp representing undigested mixture.  
 
 
 
Figure 19: scn5Laa gene F0 Mutant#15, in-frame mutation. Mutant # 15 shows 3 bp 
deletion (in-frame mutation) compared to WT strand. The highlighted portion refers to 
this protein missing valine compared to WT protein production. The gel image shows 
three bands, at 638 bp, 462 bp, and 176 bp compared to WT strand producing only one 
band at 638 bp representing undigested mixture.  
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Figure 20: scn5Laa gene F0 Mutant#17, in-frame mutation. Mutant # 17 shows 3 bp 
deletion (in-frame mutation) compared to WT strand. The highlighted portion refers to 
this protein missing methionine compared to WT protein production. The gel image 
shows three bands, at 638 bp, 462 bp, and 176 bp compared to WT strand producing 
only one band at 638 bp representing undigested mixture.  
 
 
 
 
Figure 21: scn5Laa gene F0 Mutant#4, in-frame mutation. Mutant # 4 shows 9 bp 
deletion (in-frame mutation) compared to WT strand. The mutant is missing valine, 
isoleucine, and valine from its protein product compared to WT protein production.  
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Figure 22: scn5Laa gene F0 Mutant#1, in-frame mutation. Mutant # 1 shows 6 bp 
deletion (in-frame mutation) compared to WT strand. The mutant is missing isoleucine 
and valine from its protein product compared to WT protein production.  
 
 
 
Figure 23: scn5Laa gene F0 Mutant#42, in-frame mutation. Mutant # 42 shows 3 bp 
deletion (in-frame mutation) compared to WT strand. The mutant is missing methionine 
from its protein product compared to WT protein production.  
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Figure 24: scn5Laa gene F0 Mutant#44, in-frame mutation. Mutant # 44 shows 6 bp 
deletion (in-frame mutation) compared to WT strand. The mutant is missing isoleucine 
and valine from its protein product compared to WT protein production.  
 
 
 
 
Figure 25: scn5Laa gene F0 Mutant#49, in-frame mutation. Mutant # 49 shows 3 bp 
deletion (in-frame mutation) compared to WT strand. The mutant is missing valine from 
its protein product compared to WT protein production.  
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Figure 26: scn5Laa gene F0 Mutant#52, in-frame mutation. Mutant # 52 shows 6 bp 
deletion (in-frame mutation) compared to WT strand. The mutant is missing isoleucine 
and valine from its protein product compared to WT protein production.  
 
 
 
 
Figure 27: scn5Laa gene F0 Mutant#55, in-frame mutation. Mutant # 55 shows 6 bp 
deletion (in-frame mutation) compared to WT strand. The mutant is missing isoleucine 
and valine from its protein product compared to WT protein production.  
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Figure 28: scn5Laa gene F0 Mutant#32, in-frame mutation.  
Mutant # 32 shows 3 bp deletion (in-frame mutation) compared to WT strand. The 
mutant is missing methionine from its protein product compared to WT protein 
production.  
 
 
 
Figure 29: scn5Laa gene F0 Mutant#34, in-frame mutation. Mutant # 34 shows 3 bp 
deletion (in-frame mutation) compared to WT strand. The mutant is missing valine from 
its protein product compared to WT protein production.  
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Figure 30: scn5Laa F0 Mutant#7, frameshift mutation. Mutant # 7 shows 3 bp 
deletion and 23 bp insertion (frameshift mutation) compared to WT strand. The mutant 
has 1-198 same amino acids as the WT protein product. However, amino acids 199-210 
are changed as highlighted in yellow. The protein product of this mutant is only 210 
amino acids compared to WT protein product of 1932 amino acids.  
 
 
 
 
  
Figure 31: Gel Image to show scn5Lab mutation in F0 Generation embryos 
microinjected with TALENs.  Lane 1 and 5 show scn5Lab undigested  and WT 
control, respectively representing a single band at 361 bp. Lane 2 shows WT PCR 
product digested with ApaI showing two bands at 310 bp and 104 bp indicating no sign 
of indel mutation in the spacer region of the TALENs targeted site. Lane 4 contains 
samples from bulk screening of 30 microinjected embryos digested with ApaI. Lane 4 
shows bands at 361 bp, 310 bp, and 104 bp. The band at 361 bp represents undigested 
mixture indicating the presence of indel mutation. 
 
 
 
       1            2              3             4             5      
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      CCTGGCGCGGGGTTTCTGCATCGGGCCCTTCACATTTCTGAGGGACCCCTGGA              (WT) 
(1)  CCTGGCGCGGGGTTTCTGCATCGGGCCGCCCTTCACATTTCTGAGGGACCCCTGGA (+4) 
(2)  CCTGGCGCGGGGTTTCT-------------CACATTTCTGAGGGACCCCTGGA               (-13) 
(4)  CCTGGCGCGGGGTTTCTGCATCGGGCTCTTCACATTTCTGAGGGACCCCTGGA  (SNP) 
 
Figure 32: Sequencing results of scn5Lab F0 generation. The highlighted portion 
refers to scn5Lab TALENs forward and reverse binding sites targeted from plasmid 
scn5Lab PEAS-TALENs and PERR-TALENs, respectively. Clone #1 shows 4 bp 
insertion compared to WT strand. Clone # 2 and 4 show 13 bp deletion and single 
nucleotide polymorphism compared to WT strand.  
 
 
 
 
 
Figure 33: Sequencing results of scn5Lab Bulk Screening (CRISPR-CAS9). The 
highlighted portion in yellow refers to 23 bp CRIPSR target site for scn5Lab. Clone # 3 
shows 7 bp insertion compared to WT strand. Clone # 5 shows 6 bp insertion and 2 bp 
deletion compared to WT strand.  
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Figure 34: scn5Lab Male #3-8 F0 generation Mutation. Lanes1-2 represent PCR 
product of scn5Lab mutant #3 digested with ApaI. The upper band matches the 
undigested control shown in lane 5 producing band at 361 bp. This band shows 
presence of indel mutation in lanes 1-2. Second and third bands in lanes 1-2 are 310 bp 
and 104 bp long. Lane 4 shows WT PCR product digested with ApaI, producing two 
bands at 310 bp and 104 bp.  
 
 
Figure 35: scn5Lab Male #3-8 F0 Frameshift Caused by Indel Mutation.  
Mutant # 3-8 shows 6 bp deletion and 1 bp insertion (frameshift mutation) compared to 
WT strand. The mutant has 1-181 same amino acids as the WT protein product. 
However, amino acids 182-203 are changed as highlighted in yellow. The protein 
product of this mutant is only 203 amino acids long compared to WT protein product of 
1954 amino acids.  
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Figure 36: scn5Lab Male #5-6 F0 generation Mutation. Lane 1 represents undigested 
control at 361 bp. Lane 2 represent PCR product of scn5Lab mutant #5 digested with 
ApaI. The upper band matches the undigested control shown in lane 1 producing band 
at 361 bp. This band shows presence of indel mutation in lanes 2. Second and third 
bands in lanes 1-2 are 310 bp and 104 bp long which matches with lane 4. Lane 4 
shows WT PCR product digested with ApaI producing two bands at 310 bp and 104 bp.  
 
 
 
 
Figure 37: scn5Lab Male #5-6 F0 In-frame Mutation.  
Mutant # 5 shows 15 bp deletion (in-frame mutation) compared to WT strand. The 
mutant is missing cysteine, isoleucine, glycine, proline, and phenyalanine at positions 
180-184 compared to the WT protein product.  
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Figure 38: scn5Lab F0 CRISPR-CAS9 Mutant#21, frameshift mutation. Mutant # 21 
shows 11 bp insertion (frameshift mutation) compared to WT strand. The mutant has 
the same first six amino acids as WT. Amino acids 7-13 are changed due to frameshift 
in the coding sequence (highlighted in yellow). The final protein product of the mutant is 
13 amino acids compared to 1954 amio acid of WT protein. The gel image shows 
samples for mutant #21 and 22 after T7 endonuclease digestion. Lane 1 shows WT 
undigested control representing band at 351 bp. Lanes 2-3 produced three bands, at 
351bp, 271 bp, and 79bp compared to WT strand. The upper band represents 
undigested mixture while the last two bands represent successful T7 endonuclease 
digestion.  
 
 
 
Figure 39: scn5Laa F0 CRISPR-CAS9 Mutant#22, frameshift mutation. Mutant # 22 
shows 16 bp insertion (frameshift mutation) compared to WT strand. The mutant has 
the same first six amino acids as WT. Amino acids 7-15 are changed due to frameshift 
in the coding sequence (highlighted in yellow). The final protein product of the mutant is 
15 amino acids compared to 1954 amio acid of WT protein. 
 
           WT                        21                     22 
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Figure 40: scn5Lab F2 generation embryos showing abnormal phenotypes. The 
figure above shows various developmental defects in F2 generation homozygous null 
allele scn5Lab mutants compared to wild-type (WT) embryos at 6dpf. Black arrow 
shown in images a-d indicate cardiac edema compared to WT embryos. Green arrows 
in images a-d indicate yolk-sac edema compared to WT embryo.  
 
 
 
 
 
 
a b 
c d 
WT 
60 
 
 
  
 
Figure 41: scn5Laa embryos showing defective phenotypes post microinjection. 
The Figure above shows various developmental defects in F0 generation embryos after 
scn5Laa CRISPR-CAS9 gRNA microinjections compared to wild-type (WT) embryos 
from 50-80hpf. Black arrow shown in images a-d indicate cardiac edema compared to 
WT embryos. Green arrow in image d indicate yolk-sac edema compared to WT 
embryo. Curvature of the spine is seen in images a and b.  
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Table 10: Heartbeat Rate per minute. The above table shows heartbeat per minute of 
heterozygous (scn5Laa F1 and scn5Lab F1), homozygous (scn5Laa F2 and scn5Lab 
F2), and WT embryos at 26, 28, 31, 49, 51, 53, and 55 hpf.  
 
 
 
 
 
 
Figure 42: Heartbeat Rate comparisons. The above graph compares the heart rate of 
scn5Laa heterozygous (F1) and homozygous embryos (F2) to scn5Laa heterozygous 
(F1) and homozygous embryos (F2) and WT embryos at 26, 28, 31, 49, 51, 53, and 55 
hpf. 
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Heartbeat Rate Comparison
scn5Laa F1 scn5Laa F2 scn5Lab F1 scn5Lab F2 WT
hpf scn5Laa F1 scn5Laa F2 scn5Lab F1 scn5Lab F2 WT 
26 hpf 32 30 31 31 33 
28 hpf 46 43 45 43 46 
31 hpf 57 56 57 56 61 
49 hpf 127 120 124 125 127 
51 hpf 144 144 146 147 149 
53 hpf 140 142 145 149 148 
55 hpf 145 148 147 151 151 
CHAPTER 4: DISCUSSION 
Based on the heart developmental defects induced by antisense morpholino 
oligonucleotide (MO) gene knockdown of zebrafish genes scn5Laa and ab reported by 
Chopra et al., and assuming that these gene knockdown phenotypes were not the result 
of MO off target or toxicity effects, it was hypothesized that both the TALENs and 
CRISPR-CAS9-induced knockout mutations in the zebrafish scn5Laa and ab 
genes would phenocopy the developmental defects induced by MO’s directed 
against scn5Laa and ab by Chopra et al. (Chopra et al. 2010). To test the hypothesis 
that knockout of the zebrafish scn5Laa and ab genes would result in heart 
developmental defects characterized by cardiac and yolk sac edema, cardiac 
arrhythmia, and progressive heart deterioration, knockout mutation-bearing zebrafish 
lines of these genes were constructed. The specific TALENs and CRISPR-CAS9 
genome editing-induced knockout mutations in these lines were characterized as 
frameshift mutations that induced premature translation termination codons in gene-
transcribed mRNAs that could further lead to truncation of the proteins early in 
translation, yielding severely shortened proteins lacking even the first functional 
transmembrane coding domains. Heterozygous and homozygous frame-shift mutants 
from each mutant-bearing line showed that zebrafish embryos from these lines 
developed normally compared to wild-type control embryos. These results provide 
evidence that the scn5Laa and ab encoded proteins independently do not play a role in 
specification of embryonic heart development and suggest that the developmental 
defects produced by individual antisense MO treatment of zebrafish embryos do not 
result from direct knockdown of either scn5Laa or scn5Lab-derived mRNAs individually 
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as reported by Chopra (2008) and Chopra et al (2010). Based on these results, we 
reject the hypothesis that scn5Laa or ab gene-coded proteins independently act to 
specify normal zebrafish embryonic heart development.   
While the results from TALENs and CRISPR-CAS9 induced knockout of 
zebrafish scn5Laa and ab genes did not lead to the hypothesized developmental 
defects, there are a number of possible explanations to account for the observed 
results.  A likely explanation based on the nature of antisense MOs and the close 
sequence relationship and potential overlapping subfunctions between the scn5Laa and 
ab, is that treatment with MOs directed toward individual gene-derived mRNAs from 
either scn5Laa or ab may have inhibited the translation of both mRNAs and that dual 
knockdown is required to induce developmental defects. The MOs used by Chopra 
(2008) and Chopra et al. (2010) to knockdown post-transcriptional RNA splicing and 
mRNA translation of scn5Laa and ab included MOs directed toward the translational 
initiation start sites and splice junctions for both genes.  All the MOs used by Chopra 
(2008) and Chopra et al. (2010) induced the stereotypical heart developmental defects 
described in this thesis, including those linked to specific alleles in the human SCN5A 
gene.  Despite the differences in their target sites and modes of action, it is possible that 
the knockdown of either scn5Laa or ab independently affects the function of the other 
gene in relation to normal heart development. If this is the case, then it is possible we 
did not observe an effect of individual scn5Laa or ab knockouts because independent 
knockouts of each gene alone is insufficient to induce heart defects like those observed 
by Chopra (2008) and Chopra et al. (2010).  A test of this hypothesis will await the 
construction of double knockouts for both scn5Laa and ab in zebrafish.  Double 
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knockout mutants derived by intercrossing homozygous single knockouts for both 
scn5Laa and ab are being constructed in the laboratory and results from these crosses 
are forthcoming.  
It is also possible that the homozygous knockouts for scn5Laa or ab, while 
verified for frameshift mutations leading to premature translation termination sites in 
scn5Laa or ab-encoded mRNA at the TALENs and CRISPR-CAS9 target sites, still 
produce functional protein products and so do not show the hypothesized 
developmental defects. This result could occur if there were compensatory frameshift 
mutants induced near, but downstream, of the verified frameshifts.  By compensatory, it 
means that these frameshifts would return the mRNA coding sequence back to the 
original reading frame but at a site distant from intended and sequenced target site 
mutation. The resultant mRNA would encode a protein with a series of frameshifted 
amino acids between the verified TALENs and CRISPR-CAS9-induced frameshifts and 
the compensatory 2nd site frameshift but with a wild-type amino acid sequence 
downstream of the compensatory frameshift that would return the mRNA to the proper 
reading frame. The net effect of the compensatory frameshift would be to generate a 
protein product with an amino acid sequence comparable to wild-type with the exception 
of the amino acids encoded by the region of the mRNA bordered by the upstream and 
downstream frameshifts.  While this explanation may seem highly unlikely, given the 
spontaneous frequency of frameshift mutations, little is known about off-target effects of 
TALENs and CRISPR-CAS9-induced mutations, including those near the editing target 
site. The likelihood for such an explanation is more probable if there is strong selection 
against knockouts for these two genes. Evidence from mouse and human mutations in 
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the zebrafish orthologs of the human and mouse SCN5A gene suggest that 
homozygotes of certain alleles suffer embryonic lethality (Nuyens et al. 2001; 
Papadatos et al. 2002; Lei et al. 2005). In fact, results from this thesis suggest that 
knockouts of scn5Laa, in particular, are highly enriched for in-frame mutations (12/13 or 
92%) relative to out-of-frame (1/13 or 8%), frameshifting mutations in adult survivors of 
TALENs and CRISPR-CAS9 treatment. An excess of in-frame mutations in adult 
survivors would be expected if nonsense mutation-inducing frameshift mutations 
resulted in a preponderance of prematurely terminated protein products leading to 
embryonic lethality. Based on statistical probability, the likelihood of frameshift 
mutations early in the mRNA coding sequence of these two genes leading to premature 
termination sequences resulting in nonfunctional protein products being far greater than 
small in-frame mutations having similar effects, is very significant. The isolation of a 
comparable number of frameshift relative to in-frame mutations in bulk screening of F0 
TALENs-treated embryos (Figure 15) in contrast to a complete absence of frame-shift 
mutations in surviving adult F0 fish, argues that there is a strong selection against 
frame-shift mutations in the sites targeted. These results further argue that surviving 
frameshifted knockouts may not truly inactive the generation of a functional protein 
product. There are several ways to determine whether the ‘compensatory’ 2nd site 
frameshift hypothesis can explain the observed results.  Reverse transcription and 
sequencing of the cDNA derived from mRNA prepared from homozygous frameshifted 
knockouts would reveal whether compensatory mutations downstream from the 
TALENs and CRISPR-CAS9-induced mutations are present. This approach would 
provide direct information concerning the location of the compensatory frameshift as 
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well as the exact nature of the deduced changes in the amino acid sequences of the 
coding region between the upstream and downstream frameshifts.  An alternative and 
related but more time-consuming approach would be to sequence the PCR amplified 
genomic DNA corresponding to the exons of the gene. These results would provide the 
same information as the cDNA sequencing.  Another alternative is to determine whether 
a protein product is being synthesized and, if so, whether the protein is truncated, full 
length or slightly modified. This approach requires the availability of highly specific 
antibody for western blot analysis. While antibodies directed toward human SCN5A are 
commercially available, they have not been demonstrated to be specific either for 
human or zebrafish scn5 gene family members.  
There is also a possibility, given that protein product of both scn5Laa and ab are 
more than 1900 amino acids long, that translation initiates again at an ATG codon 
downstream of the frameshifted region in both scn5Laa and ab knockouts. This would 
make the protein product of the knockouts exactly the same as WT except from the 
frameshifted region through the secondary ATG codon. This would explain why none of 
our mutants showed expected developmentally defective phenotype. Western blot 
analysis with highly specific antibody will confirm if some other ATG codon downstream 
of the presumed initiator, a secondary site, is the source of protein product frameshifted 
mutants.  
Concerns about the potential lethality of scn5Laa knockouts, in particular, but 
also about scn5Lab knockouts prompted a series of experiments designed to examine 
the lethality and developmental defects in F0 stage zebrafish embryos microinjected 
with CRISPR-CAS9-targeting mRNAs directed toward scn5Laa. Results from these 
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experiments proved interesting but inconclusive. We constantly observed 25-35% death 
of the developing embryos injected with scn5Laa gRNA compared to 5-7% death 
among embryos in the control group. There was evidence for an excess of embryo 
mortality and developmental defect (3-10%) induction for microinjections of CRISPR-
CAS9-targeting mRNAs directed toward scn5Laa compared to control CRISPR-CAS9 
targeting other genes in the genome. However, isolation and characterization of DNA 
from developmentally defective F0 embryos revealed that the targeted sites were not 
mutated, at least at levels detectable based on sequence analysis of target site PCR- 
amplified genomic DNA. These results suggest that either the embryos exhibited 
developmental defects and excessive mortality compared to microinjected controls 
because of deleterious but undetectable mutations in scn5Laa or that the targeting 
CRISPR-CAS9 mRNA directed to scn5Laa was differentially toxic to embryos relative to 
the control CRISPR-CAS9 mRNA. It is not clear how to experimentally differentiate 
between these alternative explanations.  
It is also possible that Chopra (2008) and Chopra et al.’s knockdown treatments 
affected the translation of other Na+ ion channel family gene targets and that the 
combined effects generated their observed cardiac developmental defects. If this is the 
case, then genome-editing knockouts of other Na+ ion channel would have to be 
constructed and examined for their effects on zebrafish embryonic development. This 
explanation is considered very unlikely because it does not account for the effects 
observed for transgenic zebrafish bearing mutant alleles of the human SCN5A gene. 
As a final note, it is interesting that the construction of transgenic zebrafish with 
an integrated copy of a human SCN5A gene bearing an allele strongly linked to defects 
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in human heart function, SCN5A-D1275N, showed defects in zebrafish embryonic 
development similar to those reported by Chopra (2008) and Chopra et al. (2010).  
Moreover, these transgenic zebrafish showed increased embryonic mortality compared 
to transgenic zebrafish bearing the wild-type human SCN5A gene and to wild-type 
zebrafish.  However, transgenic zebrafish lines with the human SCN5A-D1275N-
bearing gene, showed incomplete penetrance of phenotype among the fish examined 
as did humans with this allelic form of SCN5A. These results are indicative of the 
sensitive nature and activity of allelic variants of SCN5A and may reflect the sensitivity 
of developmental phenotypes to variation in expression of this class of genes from 
humans and zebrafish. 
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APPENDIX B: Developmental defects observed by Chopra et al. in zebrafish MOs.  
 
 
 
Above embryos show various developmental defects due to knockdown of either 
scn5Laa or scn5Lab. These morpholinos show cardiac edema, yolk sac edema, 
curvature of spine, abnormal cardiac development, LQTS, Bradycardia, Sudden cardiac 
death syndrome, etc. compared to uninjected embryos. Developmental defects are 
severe in the embryos injected with both scn5Laa and scn5Lab morpholinos (Chopra et 
al. 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX C: The effects of crude oil derivities on embryonic development of 
zebrafish (de Soysa et al. 2010) 
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